Literature DB >> 15477082

The role of thioredoxin and disulfide isomerase in the expression of the snake venom thrombin-like enzyme calobin in Escherichia coli BL21 (DE3).

Shengling Yuan1, Haiqing Duan, Chunjie Liu, Xiuli Liu, Taotao Liu, Haoxia Tao, Zhaoshan Zhang.   

Abstract

Thrombin-like enzymes (TLEs) are studied widely because of their therapeutic potential in myocardial infarction and thrombotic diseases. But they are always produced in Escherichia coli BL21 (DE3) as inclusion bodies because they are single chain Cys-rich proteins. In this work, coexpressing of thioredoxin (TrxA) largely increased the solubility of calobin, one of the TLEs from korea viper Agkistrodon caliginosus, but soluble calobin-T had poor enzyme activity. Disulfide isomerase (DsbC) was introduced into the host cell and coexpressed with calobin in the presence of TrxA, the result was that both the solubility and enzyme activity of calobin-TD were higher than those of calobin-T. Although recombinant calobins exhibited the enzyme of hydrolyzing the fibrinogen, they lost clotting activity to the substrate. Recombinant calobin-TD remained poor amidolytic activity, the effects of divalent metal cations and various inhibitors on this activity were similar to those of native calobin nevertheless, suggesting that calobin-TD exhibited the characteristics of serine protease especially of trypsin-like serine protease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15477082     DOI: 10.1016/j.pep.2004.08.004

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  9 in total

1.  Chaperone-like properties of tobacco plastid thioredoxins f and m.

Authors:  Ruth Sanz-Barrio; Alicia Fernández-San Millán; Jon Carballeda; Patricia Corral-Martínez; José M Seguí-Simarro; Inmaculada Farran
Journal:  J Exp Bot       Date:  2011-09-23       Impact factor: 6.992

2.  Efficient expression of full-length antibodies in the cytoplasm of engineered bacteria.

Authors:  Michael-Paul Robinson; Na Ke; Julie Lobstein; Cristen Peterson; Alana Szkodny; Thomas J Mansell; Corinna Tuckey; Paul D Riggs; Paul A Colussi; Christopher J Noren; Christopher H Taron; Matthew P DeLisa; Mehmet Berkmen
Journal:  Nat Commun       Date:  2015-08-27       Impact factor: 14.919

3.  Characterization of Anti-Citrinin Specific ScFvs Selected from Non-Immunized Mouse Splenocytes by Eukaryotic Ribosome Display.

Authors:  Haiwei Cheng; Yifei Chen; Yi Yang; Xueqiu Chen; Xiaolu Guo; Aifang Du
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

4.  Toxin Fused with SUMO Tag: A New Expression Vector Strategy to Obtain Recombinant Venom Toxins with Easy Tag Removal inside the Bacteria.

Authors:  Lhiri H A L Shimokawa-Falcão; Maria C Caporrino; Katia C Barbaro; Maisa S Della-Casa; Geraldo S Magalhães
Journal:  Toxins (Basel)       Date:  2017-02-27       Impact factor: 4.546

5.  Functional Improvement of Human Cardiotrophin 1 Produced in Tobacco Chloroplasts by Co-expression with Plastid Thioredoxin m.

Authors:  María Ancín; Ruth Sanz-Barrio; Eva Santamaría; Alicia Fernández-San Millán; Luis Larraya; Jon Veramendi; Inmaculada Farran
Journal:  Plants (Basel)       Date:  2020-02-02

6.  Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2009-05-14       Impact factor: 5.328

7.  SHuffle, a novel Escherichia coli protein expression strain capable of correctly folding disulfide bonded proteins in its cytoplasm.

Authors:  Julie Lobstein; Charlie A Emrich; Chris Jeans; Melinda Faulkner; Paul Riggs; Mehmet Berkmen
Journal:  Microb Cell Fact       Date:  2012-05-08       Impact factor: 5.328

8.  Use of folding modulators to improve heterologous protein production in Escherichia coli.

Authors:  Olga Kolaj; Stefania Spada; Sylvain Robin; J Gerard Wall
Journal:  Microb Cell Fact       Date:  2009-01-27       Impact factor: 5.328

9.  Correlation between the glycan variations and defibrinogenating activities of acutobin and its recombinant glycoforms.

Authors:  Ying-Ming Wang; Inn-Ho Tsai; Jin-Mei Chen; An-Chun Cheng; Kay-Hooi Khoo
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.